Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Éva Balázs"'
Autor:
Éva Balázs
Publikováno v:
Romanian Economic Journal, Vol XXVI, Iss 85, Pp 49-66 (2023)
In the course of my research I conducted at the Doctoral School of the Hungarian University of Agriculture and Life Sciences (MATE), I examined the role of feelings, emotions, attitudes, and motivations in respect of economic processes and decisions.
Externí odkaz:
https://doaj.org/article/816c755e31644a1e8a0c408d5a216c2c
Autor:
Éva, Balázs
Publikováno v:
Iskolakultúra; feb/mar2024, Vol. 34 Issue 2/3, p27-46, 20p
Autor:
Vyacheslav Zhdan, Sunghyun Kim, Rene Westhovens, Jee Hye Suh, Piotr Wiland, Janusz Jaworski, Seul Gi Lee, Marek Zawadzki, Pavel Shesternya, Roman Yatsyshyn, Delina Ivanova, Sergii Shevchuk, Paweł Hrycaj, Elias Chalouhi El-Khouri, Mykola Stanislavchuk, Éva Balázs, Alfredo Berrocal Kasay, Larisa Eliseeva, Dae Hyun Yoo, Sang Joon Lee, Noo Ri Han, Jakub Trefler
Publikováno v:
Rheumatology (Oxford, England)
Objective To assess non-inferiority of s.c. to i.v. CT-P13 in RA. Methods Patients with active RA and inadequate response to MTX participated in this phase I/III double-blind study at 76 sites. Patients received CT-P13 i.v. 3 mg/kg [week (W) 0 and W2
Autor:
Andrea Everding, Jeffrey Neal, Éva Balázs, Stanley Cohen, Gary Fanjiang, MyungShin Oh, Juan Sánchez-Bursón, Rafal Wojciechowski, Tomas Hala, Mark C. Genovese
Publikováno v:
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-11 (2020)
Arthritis Research & Therapy
Arthritis Research & Therapy
Background ABP 710 is being developed as a biosimilar to infliximab reference product (RP). Analytical similarity and pharmacokinetic equivalence between the two have been previously demonstrated. Here we report results from a comparative clinical st
Autor:
Marek Zawadzki, C. Hwang, S. J. Lee, E. Chalouhi, Rene Westhovens, Éva Balázs, S. H. Kim, D. S. Choi, Jeehye Suh, A. Berrocal, Piotr Wiland, Delina Ivanova, Sergii Shevchuk, D.-H. Yoo
Publikováno v:
Annals of the Rheumatic Diseases. 79:310-311
Background:Novel subcutaneous infliximab (CT-P13 SC) was developed to augment the flexibility in therapeutic use of infliximab and noninferiority (NI) of CT-P13 SC versus CT-P13 intravenous (IV) was demonstrated for efficacy in patients with rheumato
Autor:
S. H. Kim, A. Berrocal, E. Chalouhi, D.-H. Yoo, Éva Balázs, Rene Westhovens, S. J. Lee, Y. Jung, N. Han, Sergii Shevchuk, Delina Ivanova, Piotr Wiland, Marek Zawadzki
Publikováno v:
Annals of the Rheumatic Diseases. 79:311-312
Background:In the post-hoc analysis of PLANETRA, a Phase III randomized controlled trial (RCT), no significant association was found between body mass index (BMI) and clinical responses in rheumatoid arthritis (RA) patients using weight-based intrave
Autor:
Elias Chalouhi, Yunah Kim, Delina Ivanova, Sang Joon Lee, Dae-Hyun Yoo, Jeehye Suh, Larisa Eliseeva, Alfredo Berrocal, Mykola Stanislavchuk, Sergii Shevchuk, Roman Yatsyshyn, Éva Balázs, S. J. Lee, Marek Zawadzki, Piotr Wiland, Rene Westhovens
Publikováno v:
SATURDAY, 15 JUNE 2019.
Background CT-P13 subcutaneous (SC) formulation showed comparable efficacy and safety with CT-P13 intravenous (IV) formulation in rheumatoid arthritis (RA)1 and Crohn’s disease2 preliminary studies (Part 1). Objectives The purpose of this study was
Autor:
MyungShin Oh, Jeffrey Neal, Stanley N. Cohen, Gary Fanjiang, Juan Sánchez-Bursón, Éva Balázs, Mark C. Genovese
Publikováno v:
Abstracts Accepted for Publication.
Background ABP 710 is being developed as a biosimilar to infliximab. Both ABP 710 and infliximab reference product (RP) inhibit tumor necrosis factor-alpha and have been shown to be structurally and functionally similar in analytical assessments. In
Autor:
Endre Pál, Kázmér Karádi, Sámuel Komoly, Zsuzsanna Aschermann, Katalin Takács, József Janszky, Attila Makkos, Éva Balázs, Norbert Kovács
Publikováno v:
Neuropsychobiology. 73:169-177
Background: A recent evidence-based guideline demonstrated that bilateral repetitive transcranial magnetic stimulation (rTMS) over the motor cortex (M1) can improve motor symptoms of Parkinson's disease (PD). We conducted a randomized, double-blind,
Autor:
Sámuel Komoly, Norbert Kovács, József Janszky, Éva Balázs, István Balás, Gabriella Deli, Ferenc Nagy
Publikováno v:
Parkinsonism & Related Disorders. 17:50-54
Deep brain stimulation of the subthalamic nuclei (STN) is a well established treatment in advanced Parkinson's disease (PD). Based on the clinical efficacy and elicited side-effects, both unipolar and bipolar stimulation modes may be applied. Bipolar